Avotres Announces Results from a Phase-I Trial of AVT001

This blog posting reports on the results of Avotres recent phase-I clinical trial into AVT001 and the company's future plans for testing. I reported on the start of this trial here: https://cureresearch4type1diabetes.blogspot.com/2019/12/avotress-avt001-starts-phase-i-trial.html AVT001 is an "autologous dendritic cell therapy" meaning that a person's own dendritic immune cells are taken out,…